Literature DB >> 6347474

Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.

F Herrmann, G Sieber, Z Chen, B Enders, B Komischke, H Rühl.   

Abstract

Functional properties were studied in the purified T cell fraction of patients with chronic lymphocytic leukaemia of the B cell type (B-CLL). This analysis included the evaluation of T suppressor activity when investigated patients' T cells were co-cultured together with allogenic normal B and OKT4 enriched T cells in the presence of pokeweed mitogen (PWM). The Ig secreting cells (ISC) were assessed in a reverse haemolytic plaque assay (RHPA). Antibody-dependent cytotoxicity (ADCC) and natural killer activity (NK) were determined in a 51Cr release assay. Furthermore, purified T cells reactive with the monoclonal antibody HNK1, known to recognize most effector cells in ADCC and NK, were enumerated using an indirect immunofluorescence. Our results revealed increased T suppressor cell activity and markedly deficient NK activity in peripheral blood lymphocytes (PBL), T cell and T gamma cell fractions from B-CLL patients, whereas ADCC potential was only increased in T cells and T gamma cells. Accordingly, T cells were recognized by HNK1 in greater numbers in B-CLL patients than in healthy subjects. Our data suggest that there may be a link between our findings and the hypogammaglobulinaemia as well as the increased incidence of second neoplasias reported in CLL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347474      PMCID: PMC1535548     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Clinical staging of chronic lymphocytic leukemia.

Authors:  K R Rai; A Sawitsky; E P Cronkite; A D Chanana; R N Levy; B S Pasternack
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

2.  In vitro functional studies of mononuclear cells in patients with CLL: evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes.

Authors:  T Han; B Dadey
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

3.  Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.

Authors:  G B Faguet
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

4.  T cell function in untreated B cell chronic lymphocytic leukemia.

Authors:  L A Fernandez; J M MacSween; G R Langley
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

5.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  B-cell neoplasia in man.

Authors:  S E Salmon; M Seligmann
Journal:  Lancet       Date:  1974-11-23       Impact factor: 79.321

7.  Isolation of normal T cells in chronic lymphatic leukaemia.

Authors:  J Wybran; S Chantler; H H Fudenberg
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

8.  Immunologic characterization of chronic lymphocytic leukemia cells.

Authors:  T L Whiteside; A Winkelstein; B S Rabin
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

9.  Subsequent neoplasia in chronic lymphocytic leukemia.

Authors:  D Manusow; B H Weinerman
Journal:  JAMA       Date:  1975-04-21       Impact factor: 56.272

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  8 in total

1.  Impaired mitogen responses of the non-leukaemic B cells from patients with chronic lymphocytic leukaemia.

Authors:  A Morgan; J Eaves; J W Mockford; V Malkovska
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  T cells in B cell chronic lymphocytic leukaemia. I. Decreased frequency of T lymphocytes secreting suppressor factor.

Authors:  A C Bloem; J C Clevers; E J Bast; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

3.  Flow cytometric analysis of T-lymphocyte subpopulations in B-cell chronic lymphocytic leukemia: correlation with clinical stage.

Authors:  M L Hautekeete; R F De Bock; D R Van Bockstaele; G C Colpin; Z N Berneman; M E Peetermans
Journal:  Blut       Date:  1987-11

4.  Mitogenic factor for T inducer/helper cells in Entamoeba histolytica extracts.

Authors:  Z C Chen; F Herrmann; F Koleski; T Diamantstein
Journal:  Acta Acad Med Wuhan       Date:  1985

5.  Lymphocyte subsets in the peripheral blood of patients with multiple myeloma and benign monoclonal gammopathy.

Authors:  F Herrmann; A Lochner; B Jauer; G Sieber; H Rühl
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  T cell subpopulations in B cell chronic lymphocytic leukaemias.

Authors:  G Semenzato; F Herrmann; K H Mills
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.

Authors:  R Foa; F Lauria; P Lusso; D Raspadori; M T Fierro; P L Tazzari; L Caudana; L Matera
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

8.  Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma.

Authors:  T Wen; H Mellstedt; M Jondal
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.